EpiCast Report:急性冠狀動脈症候群 (ACS)的流行病學預測
EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025
|出版日期||內容資訊||英文 79 Pages
|EpiCast Report:急性冠狀動脈症候群 (ACS)的流行病學預測 EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025|
|出版日期: 2016年08月08日||內容資訊: 英文 79 Pages||
全球主要7個國家 (美國、法國、德國、義大利、西班牙、英國、日本) 的急性冠狀動脈症候群 (ACS) 和確診的患者數，從2015年的2,545萬人，預計2025年增加到3,062萬人 (年度平均增加率2.03%) 。
本報告提供全球主要7個國家的急性冠狀動脈症候群 (ACS) 調查分析，疾病的背景，危險因素和合併症，全球趨勢，流行病學預測等相關的系統性資訊。
Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will be a significant public health problem as the elderly population increases around the world.
ACS is an umbrella term that describes conditions in which blood flow to the heart is blocked or reduced due to atherosclerotic plaques composed of white blood cells, cholesterol, and fat. ACS is classified into three disease entities based on evidence of heart muscle damage inferred from a person's symptoms, changes in the ST tracing of the electrocardiogram (ECG), and levels of cardiac biomarkers that signify heart muscle death.
Epidemiologists forecast that in the 7MM, the diagnosed prevalent cases of ACS will grow from 25.45 Million cases in 2015 to 30.62 Million cases in 2025, at an Annual Growth Rate (AGR) of 2.03%. Throughout the forecast period, the diagnosed prevalent cases of ACS in the US will constitute the highest proportion in the 7MM at approximately 54%.
In the 7MM, the diagnosed prevalent cases of ACS will be higher in men (61.81%) and in the age group older than 65 years (62.84%). STEMI, NSTEMI, and UA will constitute approximately 25%, 40%, and 35% of the diagnosed prevalent cases of ACS in the 7MM.
In the 7MM, epidemiologists project ACS hospitalizations to increase from 1.63 Million cases in 2015 to 1.71 Million cases in 2025 at an AGR of 0.51%. The US constitutes around 40% of the total hospitalized ACS cases in the 7MM for the year 2015 and will be the market with the highest number of cases during the forecast period. In 2015, the majority of the ACS hospitalizations occurred in men (62.85%) and in the age group older than 65 years (69.34%).
The report “EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025” provides an overview of the risk factors, comorbidities, and the global and historical trends for ACS in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast from 2015-2025 for the diagnosed prevalent cases of ACS, segmented by sex, age (in 10 year age groups from ages =25 years), and ACS type (STEMI, NSTEMI, and UA), and a 10-year epidemiological forecast for ACS hospitalizations, segmented by sex and ACS type (STEMI, NSTEMI, and UA).